Susquehanna International Group, LLP Agios Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $2.43 Million - $2.93 Million	-59,000 Reduced 90.49%	6,200 $275,000
Q2 2024 Aug 15, 2024	BUY	$27.55 - $48.83 $214,890 - $380,874	7,800 Added 13.59%	65,200 $2.81 Million
Q1 2024 May 07, 2024	BUY	$21.32 - $34.81 $1.22 Million - $2 Million	57,400 New	57,400 $1.68 Million
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $426,300 - $493,150	17,500 Added 42.68%	58,500 $1.45 Million
Q2 2023 Aug 11, 2023	SELL	$21.38 - $29.19 $153,936 - $210,168	-7,200 Reduced 14.94%	41,000 $1.16 Million
Q1 2023 May 16, 2023	BUY	$21.74 - $30.93 $760,900 - $1.08 Million	35,000 Added 265.15%	48,200 $1.11 Million
Q4 2022 Feb 14, 2023	SELL	$24.81 - $31.52 $449,061 - $570,512	-18,100 Reduced 57.83%	13,200 $370,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $243,875 - $426,750	12,500 Added 66.49%	31,300 $885,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $126,243 - $232,508	7,400 Added 64.91%	18,800 $417,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $2.11 Million - $2.75 Million	-79,100 Reduced 87.4%	11,400 $332,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $2.47 Million - $4.15 Million	-83,400 Reduced 47.96%	90,500 $2.98 Million
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $1.12 Million - $1.55 Million	-26,600 Reduced 13.27%	173,900 $8.03 Million
Q2 2021 Aug 11, 2021	BUY	$52.06 - $61.27 $1.61 Million - $1.9 Million	31,000 Added 18.29%	200,500 $11.1 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $2.89 Million - $3.76 Million	-65,400 Reduced 27.84%	169,500 $8.75 Million
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $5.34 Million - $7.48 Million	160,700 Added 216.58%	234,900 $10.2 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $1.57 Million - $2.6 Million	-46,500 Reduced 38.53%	74,200 $2.6 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $265,265 - $411,796	-7,700 Reduced 6.0%	120,700 $6.46 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $3.71 Million - $6.33 Million	-117,700 Reduced 47.83%	128,400 $4.56 Million
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $5.85 Million - $9.84 Million	-194,500 Reduced 44.14%	246,100 $11.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $7.22 Million - $11 Million	222,700 Added 102.2%	440,600 $14.3 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $4.42 Million - $6.52 Million	95,800 Added 78.46%	217,900 $10.9 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $385,728 - $568,428	-8,400 Reduced 6.44%	122,100 $8.23 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $1.46 Million - $2.62 Million	34,200 Added 35.51%	130,500 $6.02 Million
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $3.69 Million - $4.74 Million	-51,500 Reduced 34.84%	96,300 $7.43 Million
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $131,796 - $179,190	1,800 Added 1.23%	147,800 $12.4 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $3.39 Million - $4.9 Million	56,600 Added 63.31%	146,000 $11.9 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $714,044 - $990,921	13,700 Added 18.1%	89,400 $5.11 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $4.16 Million - $5.08 Million	75,700	75,700 $5.05 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$315 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$309 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$271 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$208 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$158 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account